Sen. Tammy Baldwin (D-Wis.) and Republican challenger Eric Hovde squared off on a debate stage Friday evening in Madison in a ...
Layoffs concentrate in automotive, engineering, banking, tech, oil, pharmaceutical sectors with no signs of slowing - Anadolu ...
As companies prepare for the upcoming proxy and annual report season, the following lists some of the key items to ...
Here are some regions that are attracting biotech and pharma companies.
Lincoln Yards developer Sterling Bay plans to sell the biotech center near the North Side development as it faces challenges ...
“The RFK announcement has kind of scrambled some of the traditional thinking [about] a lot of the people that have been ...
Amicus Therapeutics settled litigation with Teva, preventing a generic version of Galafold for Fabry Disease until 2037, ...
In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.
Sen. Elizabeth Warren (D-Mass.) and Rep. Jan Schakowsky (D-Ill.) have introduced legislation that would require ...
Two billion dollars in investments. 4,500 employees. Regeneron has grown into a major economic engine — and it's now ...
Investor's Business Daily on MSN15h
Profitable Biotech In Buy Zone As Earnings Approach
This biotech stock hit a buy point and a new high. The company's sales and earnings continue to grow with earnings out soon.
Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months.